Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes

International Journal of Antimicrobial Agents

Volumn 36, Issue 2, 2010, Pages 124-128

  Joloba, Moses L ^a   Kidenya, Benson R ^a   Kateete, David P ^a   Katabazi, Fred A ^a   Muwanguzi, Julian K ^a   Asiimwe, Benon B ^a   Alarakol, Simon P ^a   Nakavuma, Jessica L ^b   Bajaksouzian, Saralee ^c,d   Windau, Anne ^c,d   Jacobs, Michael R ^c,d  

^a MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^b MAKERERE UNIVERSITY   (Uganda)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Drug resistant serotypes serogroups; MefE gene; Streptococcus pneumoniae; Tn916 transposon; Transformation frequency

Indexed keywords

BACTERIAL DNA; ERYTHROMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENOME; CONTROLLED STUDY; GENE; GENETIC TRANSFORMATION; MEFE GENE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TRANSPOSON;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; HUMANS; MEMBRANE PROTEINS; MICROBIAL SENSITIVITY TESTS; PNEUMOCOCCAL INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; TRANSFORMATION, GENETIC;

EID: 77953807286     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2010.03.024     Document Type: Article

References (37)

1. Bogaert D., Hermans P.W., Adrian P.V., Rumke H.C., de Groot R. Pneumococcal vaccines: an update on current strategies. Vaccine 2004, 22:2209-2220.
2. Reinert R.R., Reinert S., van der Linden M., Cil M.Y., Al-Lahham A., Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005, 49:2903-2913.
3. Hausdorff W.P., Siber G., Paradiso P.R. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001, 357:950-952.
4. Kadioglu A., Weiser J.N., Paton J.C., Andrew P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat Rev Microbiol 2008, 6:288-301.
5. Blossom D.B., Namayanja-Kaye G., Nankya-Mutyoba J., Mukasa J.B., Bakka H., Rwambuya S., et al. Oropharyngeal colonization by Streptococcus pneumoniae among HIV-infected adults in Uganda: assessing prevalence and antimicrobial susceptibility. Int J Infect Dis 2006, 10:458-464.
6. Appelbaum P.C., Bhamjee A., Scragg J.N., Hallett A.F., Bowen A.J., Cooper R.C. Streptococcus pneumoniae resistant to penicillin and chloramphenicol. Lancet 1977, 2:995-997.
7. Jacobs M.R., Koornhof H.J., Robins-Browne R.M., Stevenson C.M., Vermaak Z.A., Freiman I., et al. Emergence of multiply resistant pneumococci. N Engl J Med 1978, 299:735-740.
8. Mera R.M., Miller L.A., Daniels J.J., Weil J.G., White A.R. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project. Diagn Microbiol Infect Dis 2005, 51:195-200.
9. Trzcinski K., Thompson C.M., Lipsitch M. Single-step capsular transformation and acquisition of penicillin resistance in Streptococcus pneumoniae. J Bacteriol 2004, 186:3447-3452.
10. Felmingham D., Farrell D.J., Reinert R.R., Morrissey I. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000). J Infect 2004, 48:39-55.
11. Pantosti A., Gherardi G., Conte M., Faella F., Dicuonzo G., Beall B. A novel, multiple drug-resistant, serotype 24F strain of Streptococcus pneumoniae that caused meningitis in patients in Naples, Italy. Clin Infect Dis 2002, 35:205-208.
12. Rantala M., Huikko S., Huovinen P., Jalava J. Prevalence and molecular genetics of macrolide resistance among Streptococcus pneumoniae isolates collected in Finland in 2002. Antimicrob Agents Chemother 2005, 49:4180-4184.
13. Camargos P., Fischer G.B., Mocelin H., Dias C., Ruvinsky R. Penicillin resistance and serotyping of Streptococcus pneumoniae in Latin America. Paediatr Respir Rev 2006, 7:209-214.
14. Clarke S.C., Scott K.J., McChlery S.M. Erythromycin resistance in invasive serotype 14 pneumococci is highly related to clonal type. J Med Microbiol 2004, 53:1101-1103.
15. Garcia-Suarez Mdel M., Villaverde R., Caldevilla A.F., Mendez F.J., Vazquez F. Serotype distribution and antimicrobial resistance of invasive and non-invasive pneumococcal isolates in Asturias, Spain. Jpn J Infect Dis 2006, 59:299-305.
16. Jacobs M.R., Good C.E., Beall B., Bajaksouzian S., Windau A.R., Whitney C.G. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J Clin Microbiol 2008, 46:982-990.
17. Imöhl M., Reinert R.R., Ocklenburg C., van der Linden M. Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease. J Clin Microbiol 2010, 48:1291-1296.
18. Mokaddas E.M., Rotimi V.O., Albert M.J. Implications of Streptococcus pneumoniae penicillin resistance and serotype distribution in Kuwait for disease treatment and prevention. Clin Vaccine Immunol 2008, 15:203-207.
19. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria. A report on the Rockefeller University Workshop. N Engl J Med 1994, 330:1247-1251.
20. Johnsborg O., Kristiansen P.E., Blomqvist T., Havarstein L.S. A hydrophobic patch in the competence-stimulating peptide, a pneumococcal competence pheromone, is essential for specificity and biological activity. J Bacteriol 2006, 188:1744-1749.
21. Claverys J.P., Dintilhac A., Mortier-Barriere I., Martin B., Alloing G. Regulation of competence for genetic transformation in Streptococcus pneumoniae. Soc Appl Bacteriol Symp Ser 1997, 26:32S-41S.
22. Morrison D.A. Streptococcal competence for genetic transformation: regulation by peptide pheromones. Microb Drug Resist 1997, 3:27-37.
23. Pozzi G., Masala L., Iannelli F., Manganelli R., Havarstein L.S., Piccoli L., et al. Competence for genetic transformation in encapsulated strains of Streptococcus pneumoniae: two allelic variants of the peptide pheromone. J Bacteriol 1996, 178:6087-6090.
24. Mortier-Barriere I., Humbert O., Martin B., Prudhomme M., Claverys J.P. Control of recombination rate during transformation of Streptococcus pneumoniae: an overview. Streptococcus pneumoniae: molecular biology and mechanism of disease. 2000, 57-66. Mary Ann Liebert, Inc., New Rochelle, NY. A. Tomasz (Ed.).
25. Lau G.W., Haataja S., Lonetto M., Kensit S.E., Marra A., Bryant A.P., et al. A functional genomic analysis of type 3 Streptococcus pneumoniae virulence. Mol Microbiol 2001, 40:555-571.
26. Hsieh Y.C., Wang J.T., Lee W.S., Hsueh P.R., Shao P.L., Chang L.Y., et al. Serotype competence and penicillin resistance in Streptococcus pneumoniae. Emerg Infect Dis 2006, 12:1709-1714.
27. Weiser J.N., Kapoor M. Effect of intrastrain variation in the amount of capsular polysaccharide on genetic transformation of Streptococcus pneumoniae: implications for virulence studies of encapsulated strains. Infect Immun 1999, 67:3690-3692.
28. Kamerling J.P. Pneumococcal polysaccharides: a chemical view. Streptococcus pneumoniae: molecular biology and mechanisms of disease 2000, 81-114. Mary Ann Liebert, Inc., New Rochelle, NY. A. Tomasz (Ed.).
29. Trzcinski K., MacNeil A., Klugman K.P., Lipsitch M. Capsule homology does not increase the frequency of transformation of linked penicillin binding proteins PBP 1a and PBP 2x in Streptococcus pneumoniae. Antimicrob Agents Chemother 2005, 49:1591-1592.
30. Cerda Zolezzi P., Laplana L.M., Calvo C.R., Cepero P.G., Erazo M.C., Gomez-Lus R. Molecular basis of resistance to macrolides and other antibiotics in commensal viridans group streptococci and Gemella spp. and transfer of resistance genes to Streptococcus pneumoniae. Antimicrob Agents Chemother 2004, 48:3462-3467.
31. Dowson C.G., Coffey T.J., Spratt B.G. Origin and molecular epidemiology of penicillin-binding-protein-mediated resistance to β-lactam antibiotics. Trends Microbiol 1994, 2:361-366.
32. Potgieter E., Chalkley L.J. Reciprocal transfer of penicillin resistance genes between Streptococcus pneumoniae, Streptococcus mitior and Streptococcus sanguis. J Antimicrob Chemother 1991, 28:463-465.
33. Lefrancois J., Samrakandi M.M., Sicard A.M. Electrotransformation and natural transformation of Streptococcus pneumoniae: requirement of DNA processing for recombination. Microbiology 1998, 144:3061-3068.
34. Del Grosso M., Camilli R., Libisch B., Fuzi M., Pantosti A. New composite genetic element of the Tn916 family with dual macrolide resistance genes in a Streptococcus pneumoniae isolate belonging to clonal complex 271. Antimicrob Agents Chemother 2009, 53:1293-1294.
35. Doktor S.Z., Shortridge V.D., Beyer J.M., Flamm R.K. Epidemiology of macrolide and/or lincosamide resistant Streptococcus pneumoniae clinical isolates with ribosomal mutations. Diagn Microbiol Infect Dis 2004, 49:47-52.
36. Musher D.M., Dowell M.E., Shortridge V.D., Flamm R.K., Jorgensen J.H., Le Magueres P., et al. Emergence of macrolide resistance during treatment of pneumococcal pneumonia. N Engl J Med 2002, 346:630-631.
37. Tait-Kamradt A., Davies T., Appelbaum P.C., Depardieu F., Courvalin P., Petitpas J., et al. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob Agents Chemother 2000, 44:3395-3401.